Hospital cost and length of stay in idiopathic pulmonary fibrosis

References

• Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;183:431-40
   PubMed Web of Science ®Google Scholar
• Olson AL, Swigris JJ, Lezotte DC, et al. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007;176:277-84
   PubMed Web of Science ®Google Scholar
• Fernández Pérez ER, Daniels CE, Schroeder DR, et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest 2010;137:129-37
   PubMed Web of Science ®Google Scholar
• Raghu G, Chen S-Y, Yeh W-S, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11. Lancet Respir Med 2014;2:566-72
   PubMed Web of Science ®Google Scholar
• Ley B, Collard H. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol 2013;5:483-92
   PubMedGoogle Scholar
• Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005;142:963-7
   PubMed Web of Science ®Google Scholar
• Song JW, Hong S-B, Lim C-M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J 2011;37:356-63
   PubMed Web of Science ®Google Scholar
• Natsuizaka M, Chiba H, Kuronuma K, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 2014;190:773-9
   PubMed Web of Science ®Google Scholar
• Brown AW, Fischer CP, Shlobin OA, et al. Outcomes after hospitalization in idiopathic pulmonary fibrosis. Chest 2015;147:173-9
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824
   PubMed Web of Science ®Google Scholar
• Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 2015;192:e3-19
   PubMed Web of Science ®Google Scholar
• Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015;34:1-15
   PubMed Web of Science ®Google Scholar
• King TE, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-92
   PubMed Web of Science ®Google Scholar
• Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-82
   PubMed Web of Science ®Google Scholar
• Collard HR, Ward AJ, Lanes S, et al. Burden of illness in idiopathic pulmonary fibrosis. J Med Econ 2012;15:829-35
   PubMedGoogle Scholar
• Collard HR, Chen S-Y, Yeh W-S, et al. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older. Ann Am Thorac Soc 2015;12:981-7
   PubMed Web of Science ®Google Scholar
• Houchens R, Ross D, Elixhauser A, et al. Nationwide Inpatient Sample (NIS) redesign final report [Internet]. US Agency for Healthcare Research and Quality; April 2014 (Report No.: 2014–04). http://www.hcup-us.ahrq.gov/reports/methods/methods.jsp. Accessed Dec 15, 2015
   Google Scholar
• APR DRG Software: 3M Health Information Systems - US [Internet]; 2013. Available from: http://solutions.3m.com/wps/portal/3M/en_US/Health-Information-Systems/HIS/Products-and-Services/Products-List-A-Z/APR-DRG-Software/. Accessed April 25, 2016
   Google Scholar
• Hwang W, Weller W, Ireys H, et al. Out-of-pocket medical spending for care of chronic conditions. Health Aff (Millwood) 2001;20:267-78
   PubMed Web of Science ®Google Scholar
• Inflation Calculator: Bureau of Labor Statistics [Internet]; 2013. http://www.bls.gov/data/inflation_calculator.htm. Accessed April 25, 2016
   Google Scholar
• Mooney J, Raimundo K, Chang E, et al. Mortality, costs, and length of stay in patients with idiopathic pulmonary fibrosis. Poster session presented at the American Thoracic Society 2016 International Conference; May 13, 2016; San Francisco, CA
   Google Scholar
• Muhlestein D. What types of hospitals have high charge-to-reimbursement ratios? [Internet]. Health Affairs; 2013. Available from: http://healthaffairs.org/blog/2013/07/15/what-types-of-hospitals-have-high-charge-to-reimbursement-ratios/. Accessed April 23, 2016
   Google Scholar
• Yu YF, Wu N, Chuang C-C, et al. Patterns and economic burden of hospitalizations and exacerbations among patients diagnosed with idiopathic pulmonary fibrosis. J Manag Care Spec Pharm 2016;22:414-23
   PubMedGoogle Scholar
• Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005;171:1040-7
   PubMed Web of Science ®Google Scholar
• Stern JB, Mal H, Groussard O, et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest 2001;120:213-19
   PubMed Web of Science ®Google Scholar
• Saydain G, Islam A, Afessa B, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Respir Crit Care Med 2002;166:839-42
   PubMed Web of Science ®Google Scholar
• Al-Hameed FM, Sharma S. Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. Can Respir J 2004;11:117-22
   PubMedGoogle Scholar
• Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006;174:810-16
   PubMed Web of Science ®Google Scholar
• Esposito DB, Lanes S, Donneyong M, et al. Idiopathic pulmonary fibrosis in United States automated claims. Incidence, prevalence, and algorithm validation. Am J Respir Crit Care Med 2015;192:1200-7
   PubMed Web of Science ®Google Scholar
• Quan H, Li B, Duncan Saunders L, et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database: assessing validity of ICD-9-CM and ICD-10. Health Serv Res 2008;43:1424-41
   PubMed Web of Science ®Google Scholar
• Valapour M, Skeans MA, Heubner BM, et al. OPTN/SRTR 2013 annual data report: lung. Am J Transplant 2015;15(Suppl 2):1-28
   PubMed Web of Science ®Google Scholar
• Schnitzler MA, Skeans MA, Axelrod DA, et al. OPTN/SRTR 2013 annual data report: economics. Am J Transplant 2015;15(Suppl 2):1-24
   PubMedGoogle Scholar